Latest filing published 17 Sept 2026 for 오리엔트바이오.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
장재진: trading record in brief
장재진, listed as chief executive, appears in our data through filings on 오리엔트바이오 shares, published by DART (FSS). The record holds 3 filings, for trades running from 13 March 2026 to 17 September 2026.
On the market, this insider has only sold: 2 sales. The totals do not cover 2 filings with an undisclosed amount.
The latest filing, published on 17 September 2026, reports a transaction in 오리엔트바이오. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 장재진
Open company profiles for insider transactions, fundamentals and analyst consensus when available.